DRAP launches advisory to combat antimicrobial resistance

DRAP issues advisory to combat antimicrobial resistance and self-medication.

The Drug Regulatory Authority of Pakistan (DRAP) announced an advisory aimed at addressing the growing threat of Antimicrobial Resistance (AMR) and curbing the dangerous trend of self-medication.

Moreover, DRAP Chief Executive Officer, Asim Rauf, highlighted that the misuse and overuse of antibiotics, often due to self-medication, is diminishing the effectiveness of crucial medications.

Data from the local pharmaceutical industry reveals that Pakistan consumed antibiotics worth approximately Rs. 135 billion in 2022, with 70% to 80% being prescribed unnecessarily for self-limiting conditions.

Read More: Pakistani salaried workers demand tax reduction in letter to PM

The sale of antibiotics without a prescription in low- and middle-income countries (LMICs), including Pakistan, has exacerbated the issue, leading to widespread misuse and abuse.

In addition, DRAP plans to collaborate with the Pakistan Medical and Dental Council (PMDC) and healthcare commissions to address and take action against healthcare professionals who prescribe antibiotics improperly.

Additionally, the pharmaceutical industry will face strict measures to prevent incentives for inappropriate antibiotic prescriptions.